US2024018546A1PendingUtilityA1

Single cycle replicating adenovirus vectors

Assignee: MAYO FOUND MEDICAL EDUCATION & RESPriority: Mar 6, 2008Filed: Sep 15, 2023Published: Jan 18, 2024
Est. expiryMar 6, 2028(~1.6 yrs left)· nominal 20-yr term from priority
A61K 39/00C12N 15/86A61K 39/12A61K 2039/542C12N 2710/10343A61P 35/00A61P 37/04
85
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

This document relates to adenovirus vectors and methods and materials related to using adenovirus vectors. For example, viruses, nucleic acid molecules encoding viruses, cell lines containing viral vectors, and methods for using viruses to deliver nucleic acid to cells in vitro or in vivo are provided. Methods and materials for using adenovirus vectors to induce immune responses and to treat cancer also are provided.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A method for inducing an immune response against an antigen in a mammal, wherein said method comprises administering an adenovirus to said mammal under conditions wherein said adenovirus infects a cell of said mammal, wherein said adenovirus comprises an adenovirus polypeptide and lacks at least a portion of a nucleic acid sequence that encodes said adenovirus polypeptide, wherein said adenovirus comprises a nucleic acid sequence encoding said antigen, and wherein expression of said antigen in said cell leads to induction of said immune response.

Join the waitlist — get patent alerts

Track US2024018546A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.